Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML [13]

Leukemia

Volumn 20, Issue 6, 2006, Pages 1187-1189

  Stevens Kroef, M J P L ^a   Schoenmakers, E F P M ^a   van Kraaij, M ^a   Huys, E ^a   Vermeulen, S ^a   van der Reijden, B ^a   van Kessel, A Geurts ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; LOMUSTINE; TAMOXIFEN; TRANSCRIPTION FACTOR RUNX1; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD ANALYSIS; BREAST CANCER; CANCER RISK; CHROMOSOME 21Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; GENE FUNCTION; GENE FUSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC TRANSCRIPTION; HUMAN; LETTER; LEUKEMIA RELAPSE; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33744502344     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404210     Document Type: Letter

References (9)

1. Slovak ML, Bedell V, Popplewell L, Arber DA, Schoch C, Slater R. 21q22 Balanced chromosome aberrations in therapy-related hematopoietic disorders: Report from an international workshop. Genes Chromosomes Cancer 2002; 33: 379-394.
2. Roulston D, Espinosa III R, Nucifora G, Larson RA, Le Beau MM, Rowley JD. CBFA2 (AML1) Translocations with novel partner chromosomes in myeloid leukemias: Association with prior therapy. Blood 1998; 92: 2879-2885.
3. Webb DKH, Passmore SJ, Hann IM, Harrison G, Wheatley K, Chessells JM. Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. Br J Haematol 2002; 117: 33-39.
4. Hromas R, Shopnick R, Jumean HG, Bowers C, Varella-Garcia M, Richkind K. A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. Blood 2000; 95: 4011-4013.
5. Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T et al. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosomes Cancer 2005; 44: 265-270.
6. Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, Yokota J et al. A novel gene, MEL, mapped to 1p36.3 is highly homologous to the MDS1/ EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 2000; 96: 3209-3214.
7. Nucifora F, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J et al. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci USA 1994; 91: 4004-4008.
8. Zent CS, Mathieu C, Claxton DF, Zhang D-E, Tenen DG, Rowley JD et al. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. Proc Natl Acad Sci USA 1996; 93: 1044-1048.
9. Senyuk V, Chakraborty S, Mikhail FM, Zhao R, Chi Y, Nucifora G. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells. Oncogene 2002; 21: 3232-3240.